Interview
Francis Collins: National Institutes of Health (NIH) | Lex Fridman Podcast #238
- Virus origin is predicted to be natural, likely originating in bats with an intermediate host, a process that may take years to resolve and requires finding the missing host for definitive confirmation.
- Current geopolitical tensions between the U.S. and China are expected to hinder the collection of telling information regarding virus origins, as investigations are currently impeded by these factors.
- Gain-of-function research is viewed as beneficial if safe, though the speaker anticipates that declining costs and ease of access will increase risks of misuse, potentially allowing bioweapon creation outside high-security laboratories or via leaked man-made viruses.
- There is a concern that future variants may emerge from low- and middle-income countries with limited vaccine access, potentially rendering current vaccines ineffective, though mRNA technology allows for rapid redesign and testing with a few thousand participants.
- Testing capacity is projected to reach approximately 410 million tests by December, with potential to exceed half a billion monthly if one or two additional platforms receive approval.
- Recent analyses indicate ivermectin likely does not work, while the ACTIV-6 trial results are expected within a month, and current death tolls stand at 700,000 globally with an estimated 100,000 unnecessary deaths among unvaccinated individuals.
- The speaker anticipates a shift in scientific communication toward humility rather than authority to combat the erosion of objective truth, noting that Delta variants like AY4 may continue to evolve without the pandemic being concluded by the current variant.
- Personal timelines indicate the speaker, aged 71, is working 100 hours weekly and plans to step down eventually to consider future contributions, with a second edition of The Language of God potentially ready.